Lupron Class Action
If you received Lupron for the treatment of prostate cancer or endometriosis, read on for some important information you need to know.
According to the National Cancer Institute, there were 241,740 new cases and 28,170 deaths from prostate cancer in the U.S. in 2012. Millions of women in the U.S. suffer with endometriosis, and nearly half all women in the U.S. have been diagnosed with fibroids. These individuals likely have received Lupron as part of their treatment.
Lupron, or leurolide, is a man-made hormone that reduces the amount of estrogen in women or testosterone in men. It is available by prescription only and is used in the treatment of endometrosis and fibroids in women and prostate cancer in men. Lupron is administered through injection under the skin or into a muscle. A patient may be instructed on how to self-inject himself or herself at home. Injections are typically either once a month or every three to six months, depending on the condition being treated.
FDA Investigates Lupron
In 2010, the FDA conducted a safety review of Lupron and other GnRH agonists (testosterone-suppressing drugs) amid reports of increased risk of cardiovascular disease and diabetes in men and bone density loss in women who received Lupron. The review prompted several labeling changes to ensure patient safety. The drug manufacturer, Abbott Laboratories, updated their product labeling and website to include information on these specific risks. For patients who whose lives were affected by Lupron, however, updating product labels is not enough. They want Lupron to be taken off the market.
Lupron Side Effects
Side effects associated with Lupron include:
- Bone pain
- Chest pain that radiates to the shoulder or arm
- High blood sugar
- Pain, burning, bruising or redness where Lupron was injected
- Loss of movement in any part of the body
- Rapid weight gain, swelling
- Urinating more frequently; painful or difficult urination
- Dry cough and/or wheezing
- Feeling like you’re going to faint
- Sudden headache accompanied with vomiting, blurry vision, confusion, fainting, weak pulse, slow breathing or slow heart rate
Major Pharmaceutical Pays $150 Million to Lupron Victims
Currently there are many websites dedicated to Lupron victims who wish to network and discuss the possibility of filing lawsuits. To date, no class action lawsuit has been filed against Abbott Laboratories for marketing an unsafe drug, but it’s only a matter of time with hundreds of Lupron victims who are eager to hold the company accountable. It wouldn’t be the first time the company ended up in legal hot water over Lupron.
Prescription Access Litigation (PAL), a national coalition of health and human service organizations and consumers, filed a lawsuit in federal court in 2001 against TAP Pharmaceuticals Products (TAP), Inc, Abbott Laboratories and Takeda Pharmaceutical Company, Ltd. The suit accused the defendants of intentionally inflating the average wholesale price of Lupron, forcing patients to pay more for the drug than they should have. The suit also alleged that physicians received free samples of Lupron and charged patients for them and they received monetary incentives to sell Lupron. The federal government brought civil and criminal charges against TAP, to which the firm plead guilty and agreed pay $875 in penalties. In 2004, TAP agreed to pay $150 million to settle with victims of their fraudulent scheme.
Did Your Health Suffer From Using Lupron?
AttorneyOne.com is a free nationwide legal referral service. We are not a law firm. We help consumers find the best representation for their legal needs.
If you or a loved one are in need of legal assistance concerning Lupron you should get a lawyer on your side immediately. You will pay no attorney fees unless you win your case.
Email up to 10 Lupron law firms in one click; by filling out the simple Free Case Evaluation form.
For additional info on Lupron use the practice area links on the far right.